Watch Ticker

Inhibikase Therapeutics, Inc. Common Stock

Go to Inhibikase Therapeutics, Inc. Common Stock Website

$1.80

0.00 (0.00%)

Live

Previous Close

$1.8

Day Range

$0 - $0

Previous Day Range

$1.57 - $1.83

Market Cap

$118.9 million USD

Day Vol.

Previous Day Vol.

145478

Currency

USD

Primary Exchange

Nasdaq

Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinas...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Mariusz Cholewa - BIK-Datenanalyse zeigt: Die Aufnahme von BNPL-Transaktionsdaten in die Kredithistorie könnte fast jedem zweiten „Thin-file-Kunden“ helfen, seine Kreditwürdigkeit zu verbessern

A Polish credit bureau analysis reveals that including Buy Now Pay Later (BNPL) transaction data in credit histories could help nearly 40% of 'thin-file' bank customers improve their creditworthiness, with BNPL transactions showing high repayment rates and low default risks.

Related tickers: IKT.

Read Full Article

Professor Ari Zoldan - Top 10 Small-Cap Stocks to Watch in 2025

The article discusses 10 small-cap stocks that could outperform in 2025, citing factors like falling interest rates, low valuations, and potential shifts in industrial production.

Related tickers: AUNA, CNTX, EVGO, EVGOW, FFIC, CRGO, CRGOW, IKT, OKLO, IRD, PENG, WOLF.

Read Full Article

Trending Tickers

Please sign in to view